These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

558 related articles for article (PubMed ID: 28501028)

  • 41. Treatment of unicentric and multicentric Castleman disease and the role of radiotherapy.
    Chronowski GM; Ha CS; Wilder RB; Cabanillas F; Manning J; Cox JD
    Cancer; 2001 Aug; 92(3):670-6. PubMed ID: 11505414
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Castleman Disease.
    Wang W; Medeiros LJ
    Surg Pathol Clin; 2019 Sep; 12(3):849-863. PubMed ID: 31352991
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Atypical lymphoproliferative disorders: Castleman's disease. Case report and review of the literature.
    Martino G; Cariati S; Tintisona O; Veneroso S; De Villa F; Vergine M; Monti M
    Tumori; 2004; 90(3):352-5. PubMed ID: 15315321
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Hyaline Vascular Type of Unicentric Castleman Disease in a Kidney with End-Stage Renal Disease: A Case Report of a Rare Entity at an Unusual Location and a Special Clinical Setting.
    Chen CH; Li HN
    Diagnostics (Basel); 2022 Nov; 12(11):. PubMed ID: 36428938
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The management of unicentric and multicentric Castleman's disease: a report of 16 cases and a review of the literature.
    Bowne WB; Lewis JJ; Filippa DA; Niesvizky R; Brooks AD; Burt ME; Brennan MF
    Cancer; 1999 Feb; 85(3):706-17. PubMed ID: 10091744
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Castleman disease: retrospective single-center study of therapeutic results in 10 patients].
    Szturz P; Adam Z; Rehák Z; Koukalová R; Sprláková-Puková A; Michalka J; Smardová L; Volfová P; Lengerová M; Mayer J
    Klin Onkol; 2013; 26(2):124-34. PubMed ID: 23718671
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Unicentric castleman disease is not clearly distinguished from multicentric type: a case report.
    Choi JH; Jo YJ; Gong SJ; Hong BW; Lee HJ; Son BK; Jun DW; Kim SH; Park YS; Seok JW
    Clin Lymphoma Myeloma; 2008 Aug; 8(4):256-9. PubMed ID: 18765316
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Successful use of rituximab in glomerular basement membrane nephritis associated with HIV interstitial nephritis secondary to Castleman disease
.
    Calabro N; Henriksen K; Lim SH; Kerns E
    Clin Nephrol; 2018 Jun; 89(6):469-473. PubMed ID: 29424337
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Multicentric Castleman disease and the evolution of the concept.
    Zhou T; Wang HW; Pittaluga S; Jaffe ES
    Pathologica; 2021 Oct; 113(5):339-353. PubMed ID: 34837092
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The Role of Radiation Therapy in Unicentric Castleman Disease: A Case Report.
    Rodriguez C; Rivera Rubi L; Menjivar O; Suazo J
    Cureus; 2023 Nov; 15(11):e49687. PubMed ID: 38161935
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Predominant Stroma-Rich Feature in Hyaline Vascular Variant of Castleman Disease Is Associated With Paraneoplastic Pemphigus.
    Wang L; Nong L; Li F; Wang X; Wang R; Chen X; Tu P; Dong Y; Li T; Zhu X; Wang M
    Am J Clin Pathol; 2020 Aug; 154(3):403-413. PubMed ID: 32459333
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Diagnosis and management of Castleman disease.
    Soumerai JD; Sohani AR; Abramson JS
    Cancer Control; 2014 Oct; 21(4):266-78. PubMed ID: 25310208
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Sjögren's and plasma cell variant Castleman disease: a case report.
    Dei-Adomakoh YA; Quarcoopome L; Abrahams AD; Segbefia CI; Dey DI
    Ghana Med J; 2018 Mar; 52(1):61-65. PubMed ID: 30013261
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Successfully treated multicentric Castleman's disease with renal thrombotic microangiopathy using rituximab and corticosteroid.
    Lee JP; Kim DK; Oh DY; Paik JH; Moon KC; Kim S; Kim YS
    Clin Nephrol; 2011 Feb; 75(2):165-70. PubMed ID: 21255547
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Diagnostic challenges in patients with Castleman disease, a single center experience from Hungary.
    Brúgós B; Simon Z; Méhes G; Illés Á; Pfliegler G
    Pathol Oncol Res; 2024; 30():1611785. PubMed ID: 39252787
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Unicentric Castlemans disease. Symptoms, diagnostics and therapy].
    Adam Z; Řehák Z; Adamová Z; Koukalová R; Pour L; Krejčí M; Boichuk I; Krejčí M; Štork M; Ševčíková S; Král Z
    Vnitr Lek; 2021; 67(8):465-473. PubMed ID: 35459366
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Indolent T-Lymphoblastic Proliferation in Idiopathic Multicentric Castleman Disease.
    Karki NR; Arfa AS; Savage N; Kutlar A
    Acta Haematol; 2022; 145(2):214-220. PubMed ID: 34818661
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Castleman disease presenting with ophthalmic signs and symptoms.
    Kurokawa T; Suzuki S; Kawaguchi K; Fujisawa N; Yoshimura N
    Am J Ophthalmol; 1999 Jul; 128(1):114-6. PubMed ID: 10482111
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The full spectrum of Castleman disease: 273 patients studied over 20 years.
    Oksenhendler E; Boutboul D; Fajgenbaum D; Mirouse A; Fieschi C; Malphettes M; Vercellino L; Meignin V; Gérard L; Galicier L
    Br J Haematol; 2018 Jan; 180(2):206-216. PubMed ID: 29143319
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Plasma Cell Variant Multicentric Castleman Disease and Kaposi's Sarcoma in a Treatment-Naive HIV-Infected Patient.
    Patel AS; Geller RL; Goswami ND
    AIDS Res Hum Retroviruses; 2018 Feb; 34(2):127-128. PubMed ID: 29345958
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 28.